Cullinan Oncology Inc (CGEM)

Cullinan Oncology Inc Aktie (CGEM) Neueste Nachrichten

Wedbush Reaffirms “Outperform” Rating for Cullinan Oncology (NASDAQ:CGEM) - Defense World

Defense World

Cullinan Oncology, Inc. to Post Q2 2024 Earnings of ($0.75) Per Share, Leerink Partnrs Forecasts (NASDAQ:CGEM) - Defense World

Defense World

Cullinan Oncology, Inc. (NASDAQ:CGEM) to Post Q2 2024 Earnings of ($0.74) Per Share, HC Wainwright Forecasts - Defense World

Defense World

Q2 2024 Earnings Estimate for Cullinan Oncology, Inc. Issued By Wedbush (NASDAQ:CGEM) - Defense World

Defense World

Cullinan Oncology (NASDAQ:CGEM) Price Target Lowered to $28.00 at HC Wainwright - Defense World

Defense World

Cullinan Oncology (NASDAQ:CGEM) Stock Price Down 6.6% After Analyst Downgrade - Defense World

Defense World

Cullinan Oncology (NASDAQ:CGEM) Price Target Cut to $28.00 by Analysts at HC Wainwright - MarketBeat

MarketBeat

Cullinan Oncology (NASDAQ:CGEM) Given Outperform Rating at Wedbush - MarketBeat

MarketBeat

Cullinan Oncology (NASDAQ:CGEM) Shares Down 6.6% After Analyst Downgrade - MarketBeat

MarketBeat

Cullinan Oncology stock target trimmed, maintains Buy rating - Investing.com

Investing.com

Cullinan Oncology stock target trimmed, maintains Buy rating - Investing.com India

Investing.com India

Cullinan Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results

GlobeNewswire Inc.

Short Interest in Cullinan Oncology, Inc. (NASDAQ:CGEM) Grows By 40.5% - MarketBeat

MarketBeat

Analysts Set Cullinan Oncology, Inc. (NASDAQ:CGEM) Price Target at $31.00 - MarketBeat

MarketBeat

Cullinan Oncology, Inc. (NASDAQ:CGEM) Receives Consensus Recommendation of “Buy” from Analysts - Defense World

Defense World

Cullinan Oncology, Inc. (NASDAQ:CGEM) Insider Sells $1628060.00 in Stock - Defense World

Defense World

Cullinan Oncology, Inc. (NASDAQ:CGEM) Insider Sells $1,628,060.00 in Stock - MarketBeat

MarketBeat

Cullinan Oncology, Inc. (NASDAQ:CGEM) Insider Sells $1,628,060.00 in Stock - MarketBeat

MarketBeat

Stifel Nicolaus Begins Coverage on Cullinan Oncology (NASDAQ:CGEM) - Defense World

Defense World

Stifel Nicolaus Begins Coverage on Cullinan Oncology (NASDAQ:CGEM) - Defense World

Defense World

Stifel Nicolaus Initiates Coverage on Cullinan Oncology (NASDAQ:CGEM) - MarketBeat

MarketBeat

Stifel starts Cullinan Oncology stock with buy By Investing.com - Investing.com

Investing.com

Stifel Nicolaus Initiates Coverage on Cullinan Oncology (NASDAQ:CGEM) - MarketBeat

MarketBeat

Cullinan Therapeutics Announces Appointment of Mary Kay Fenton as Chief Financial Officer

GlobeNewswire Inc.

Cullinan Oncology (NASDAQ:CGEM) Reaches New 52-Week High at $21.89 - Defense World

Defense World

Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday?

Benzinga

Cullinan Therapeutics to Present Clinical Data from Phase 1 Study Evaluating Novel Anti-MICA/B Antibody, CLN-619, as Monotherapy and in Combination with a Checkpoint Inhibitor in Patients with Advanced Solid Tumors at ASCO 2024

GlobeNewswire Inc.

Cullinan Oncology (NASDAQ:CGEM) Price Target Increased to $26.00 by Analysts at Jonestrading - Defense World

Defense World

Q2 2024 EPS Estimates for Cullinan Oncology, Inc. (NASDAQ:CGEM) Boosted by HC Wainwright - MarketBeat

MarketBeat

Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Benzinga

United Airlines Reports Upbeat Results, Joins Children's Place, Interactive Brokers And Other Big Stocks Moving Higher On Wednesday

Benzinga

BTIG boosts Cullinan Oncology shares target, highlights CLN-978's potential - Investing.com

Investing.com

Why Skillsoft Shares Are Trading Lower By Around 27%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

Benzinga

Cullinan Shifts Focus From Oncology To Autoimmune Disorders, Raises $280M Via Equity

Benzinga

UnitedHealth Reports Upbeat Earnings, Joins Cullinan Oncology, Ericsson And Other Big Stocks Moving Higher On Tuesday

Benzinga

Cullinan Management's Strategic Shift and Capital Raise - TipRanks.com - TipRanks

TipRanks

Cullinan rebrands with $280M private offering, expands beyond cancer - Boston Business Journal - The Business Journals

The Business Journals

William Blair upbeat on Cullinan Oncology stock on diverse cancer treatment pipeline - Investing.com

Investing.com

Cullinan Oncology reports Q4 EPS (54c), consensus (96c) - TipRanks.com - TipRanks

TipRanks

Here's Why We're Not Too Worried About Cullinan Oncology's (NASDAQ:CGEM) Cash Burn Situation - Yahoo Finance

Yahoo Finance

Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire Inc.

Cullinan Oncology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results - Yahoo Finance

Yahoo Finance

Ocuphire (OCUP) to Report Q4 Earnings: What's in the Cards?

Zacks Investment Research

Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for Novel MICA/B Antibody, CLN-619, for Relapsed/Refractory Multiple Myeloma

GlobeNewswire Inc.

Cullinan Oncology Announces U.S. FDA Clearance of Investigational New Drug Application for Novel MICA/B Antibody ... - Yahoo Finance

Yahoo Finance

Puma Biotechnology (PBYI) to Report Q4 Earnings: What's in Store?

Zacks Investment Research

Avalo (AVTX) to Report Q4 Earnings: What's in the Cards?

Zacks Investment Research

Sarepta (SRPT) to Report Q4 Earnings: Will It Beat Estimates?

Zacks Investment Research

Perrigo (PRGO) to Report Q4 Earnings: What's in the Cards?

Zacks Investment Research

Moderna (MRNA) Gears Up for Q4 Earnings: Will It Top Estimates?

Zacks Investment Research